Tag: pharmaceuticals
-
Biotech Gains $1M for Gut-Brain Pain Research
A biotechnology company developing treatments in the gut for mental health disorders is receiving a $1 million award for research on pain.
-
Book Review – The Premonition: A Pandemic Story
As the world struggles to overcome the Covid-19 pandemic, author Michael Lewis tells how the U.S. first struggled to identify and contain the virus.
-
AI-Designed Antibodies for Start-Up Sought in Open Call
An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company.
-
European Life Science Venture Fund Raises €472M
A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe.
-
Crispr Licensed for Eye Disease Gene Therapies
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes.
-
FDA Halts Off-the-Shelf T-Cell Cancer Trials
The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction.
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Partnership Seeks Lower-Cost Protein Drugs
A biotechnology enterprise and company aiming to make drugs at lower prices are collaborating on new lower-cost synthetic protein drugs.
-
Synthetic Antibody Company Goes Public in $230M Merger
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger.
-
Foundation Plans $1B for Longevity Research
A charitable foundation began work today supporting research on human longevity, with the goal of increasing lifespans to more than 120 years.